| Drug | Class | Adult | Paediatric | Notes |
|---|---|---|---|---|
| Vaginal dinoprostone (PGE2) pessary or gel[1] | Synthetic prostaglandin E2 | Pessary 10 mg controlled-release × 24 h; gel 1–2 mg, repeat at 6 h if no response | — | Primary cervical ripening; remove for hyperstimulation, established labour, ROM, or 30 min before oxytocin start; avoid with prior caesarean (uterine rupture risk) |
| Misoprostol (vaginal or oral)[1] | Synthetic prostaglandin E1 | Vaginal: 25 µg every 4 h × max 5 doses. Oral: 50 µg every 4 h. Sublingual 25 µg every 2 h (per local protocol) | — | Cervical ripening and labour induction; lower cost than PGE2; contraindicated with prior caesarean section (rupture risk); follow weight-based titration |
| Oxytocin (IV infusion)[1] | Synthetic oxytocin | Start 1–4 mU/min IV infusion; double every 30 min to maximum 32 mU/min titrated to 3–4 contractions in 10 min | — | After cervical ripening or with favourable cervix; continuous CTG; manage hyperstimulation by reducing rate; do not co-administer with prostaglandin within 30 min |
Indications, methods, and monitoring for elective and indicated induction of labour at term and post-dates in singleton pregnancies.